Shares of Grail, Inc. (NASDAQ:GRAL - Get Free Report) hit a new 52-week high on Thursday . The company traded as high as $39.48 and last traded at $39.26, with a volume of 1777607 shares trading hands. The stock had previously closed at $33.15.
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on GRAL shares. Morgan Stanley started coverage on Grail in a report on Wednesday, November 27th. They issued an "equal weight" rating and a $16.00 price objective on the stock. Wolfe Research started coverage on Grail in a report on Friday, November 15th. They issued a "peer perform" rating on the stock.
Get Our Latest Research Report on Grail
Grail Stock Up 11.6 %
The business has a fifty day simple moving average of $25.78 and a two-hundred day simple moving average of $18.86.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the stock. FNY Investment Advisers LLC purchased a new position in shares of Grail during the 4th quarter worth $26,000. State of Tennessee Department of Treasury purchased a new stake in Grail in the 4th quarter valued at about $28,000. Lindbrook Capital LLC purchased a new stake in Grail in the 4th quarter valued at about $28,000. Sterling Capital Management LLC purchased a new stake in Grail in the 4th quarter valued at about $29,000. Finally, Wellington Shields Capital Management LLC purchased a new stake in Grail in the 4th quarter valued at about $33,000.
About Grail
(
Get Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Further Reading
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
